When designing quantitative trials and evaluation of telehealth interventions, researchers should think ahead to the intended way that the intervention could be implemented in routine care and consider how trial participants with similar characteristics to the target population can be included. The telehealth intervention and the context in which it is placed should be clearly described, and consideration given to conducting pragmatic trials in order to show the effect of telehealth in complex environments with rapidly changing technology. Types of research designs, comparators and outcome measures are discussed and common statistical issues are introduced.
Introduction
The previous paper in this research methods series considered how to formulate one's telehealth research question and the related task of choosing the type of study and associated methods, through five stages of conceptualisation, design, pre-implementation, implementation and post-implementation. 1 This article hones in on the quantitative components of research projects conducted in the implementation stage of telehealth services, either investigating the effectiveness of an existing service or conducting a trial of a new telehealth intervention.
This paper is not a general introduction to research design and analysis, as many high quality resources already exist. For an introduction to research design readers are referred to the classic work by Shadish Campbell and Stanley, 2 and for statistical analysis we recommend two clearly written introductory books by Bland and Kirkwood and Sterne. 3, 4 We also recommend the BMJ's 'Statistics Notes' series, which contains very useful short articles on statistical tests commonly employed in health research. 5 Our aim is to apply these general principles to some of the common issues faced in quantitative telehealth research and offer potential solutions, so that researchers are prepared and can consider appropriate strategies early in their research planning. The usual PICO (Population, Intervention, Comparator, Outcomes) categories will be considered, with examples drawn from telehealth. The section on outcome measures will be brief as this will be the focus of a subsequent paper.
Population
Selecting the inclusion and exclusion criteria for the trial population is one of the key early decisions for a telehealth trial. The first issue, which is not limited to telehealth research, is of making one's criteria too narrow in order to demonstrate an 'uncontaminated' effect of the intervention. This results in many studies on telehealth interventions for chronic disease restricting the person to having only the condition being studied. Hence if one selects, say, for patients with heart failure alone and excludes those with depression or cancer or lung disease, then the study population will likely not be representative of the total population. To give a typical example, in Koehler's randomised controlled trial (RCT) of telemonitoring for heart failure, there were 18 participant exclusion criteria, including a wide range of chronic diseases. Should the differences between the study and the real world be minor this could be set aside, but we now know that most individuals who have one chronic condition also have others, with multi-morbidity being the norm, 6,7 hence Koehler's results of no significant differences between telemonitoring and usual care only apply to a very specific group of patients. Where possible, consider including a wider population group, as the results will then have greater external validity, and it will also likely make it easier to recruit participants.
Another closely related population characteristic is the severity of the condition, as how much benefit the patient receives from adding a telehealth service to usual care will often depend on how unwell they are. One of the reasons, for example, of the large Whole System Demonstrator trial showing only very modest effects on diabetes, is likely to be that all patients over aged 18 were eligible for inclusion, 8 hence there would be less room for improvement than if the sample consisted of those who were more unwell, such as those who already had diabetes complications. These types of differences may be revealed by a post-hoc subgroup analysis. This phenomenon may also explain why trials of telehealth for heart failure and stroke tend to show reductions in mortality whilst trials with other conditions do not. 9 Another major issue is that the telehealth intervention will, by definition, involve an application of technology to care delivery; therefore at a minimum the participants must be able to use the technology. Increasingly, interventions are being delivered through the participants' own devices, which often restricts telehealth services to those who have both a device such as a tablet computer or smartphone, and reliable connectivity with adequate bandwidth and a data package. In this case, the study findings will probably not be generalisable to the whole population. This is important because those most in need of telehealth are often those with least access to or ability to use technology, i.e. those with a chronic mental illness, cognitive impairment, in severe poverty, or the frail elderly. This phenomenon is termed the 'digital divide'. 10 
Intervention Complexity
Many clinical trials test simple interventions, such as comparing one drug treatment to another, but most telehealth interventions are complex. Introducing telehealth changes who delivers the care, where and how it is delivered, referral pathways and the type of care. In short, usually the whole model of care is altered. 11, 12 Even a telemedicine service that is intended to be a direct substitution, for example conducting mental health assessments by video consultation instead of in-person, still alters referral pathways, waiting lists, and patient access to care, thus having a ripple effect on health services. Craig et al. give useful guidance on developing and evaluating complex interventions in health. 13 At the write-up phase, researchers are strongly recommended to use the TIDieR checklist as an aide to providing clear descriptions of interventions, which gives enough information to those seeking to do a meta-analysis, or implement the intervention themselves. 14 
Context
Context is important in telehealth research: an intervention always occurs within a health system, which should be clearly described or otherwise referred to in the research report. The baseline level of usual care varies across countries, and also within countries for different population groups, and this can be a major influence on how much improvement might be expected from introducing telehealth. Where there is little access to healthcare, telehealth can add more value than in an environment where universal and timely access already exists.
Technology change
That technology is changing so rapidly should compel those commencing a telehealth trial to consider how dated the research is likely to be in five years' time. The time lag from grant application to implementation, analysis, write up and publication can be several years, 15 meaning there is a high risk of producing a nicely written report on the impact of obsolete technology. At the publication stage, the researchers may then need to mount an argument about the relevance of their intervention to the current environment.
In tackling this issue, researchers could think more about the functions and concepts of the technology than the specific make or model, and ask if these are generalisable. Is one social media platform, text messaging application, or home telehealth box sufficiently like another to be interchangeable for the purpose of the research? Much research on video consultations, for example, remains current, and changes such as introducing high definition, have arguably not made a great deal of difference. Adding a wholly new component, such as haptic communication (digital transmission of touch), would be transformative by allowing physical examination at a distance, but is presently only in the experimental phase.
Reports of the costs of telehealth services are especially liable to become outdated, with technology costs changing even faster than their functions. Hence the importance of conducting a sensitivity analysis to consider the outcomes if, for example, the costs were halved, quartered or borne mainly by patients using their own devices. If the major costs are health provider salaries or reimbursement, a sensitivity analysis may reveal that changing technology costs make little difference to cost-effectiveness, but for studies in which the intervention is partly or wholly automated, reductions in technology costs can lead to substantial differences.
Pragmatic trials
In a classic explanatory trial the intervention and the environment are determined at the outset and controlled as much as possible, but as telehealth is set within complex changing environments, researchers could consider the alternative of a pragmatic trial. In a pragmatic trial the best available intervention, which may change over time, is compared to usual care, and the intervention is delivered across the widest possible range of participants, within a functioning clinical setting. 16 Such a trial is thus best able to answer the question ''But does it work in the real world?''
Comparator

Selecting a comparator
The comparator is the alternative selected to show the effect of the intervention. The comparator should not be an afterthought, but a clinically meaningful choice reflecting real world practice, based on the research question and type of intervention. 17 Table 1 gives a classification of the major types of comparisons in telehealth research.
The blended model covers a variety of comparisons where there is a telehealth component to each arm of the study, with or without aspects of usual care. Issues that can arise are illustrated by a study that measured agreement between online geriatric assessment and in-person assessment in which both groups used a sophisticated case preparation system which was not available in hospital wards. The difference in study outcomes may have been greater if the in-person arm only allowed the specialist to read the patient notes, which is more typical of usual care. Generally, the blended model will either dilute the impact of the telehealth model of service (if it improves care) or reduce the difference (if it is not inferior).
Comparative research designs
Randomised parallel studies in which each arm is measured contemporaneously give a greater degree of confidence in answering the research question, but achieving this can be challenging in health services research. When the introduction of telehealth is driven by clinical need or policy directives, it may be difficult to find sufficient untainted sites to run an RCT. If it is known that the health system is going to be altered, designs without a contemporaneous comparator can be considered, such as a prospective before-and-after study, coupled with a regression analysis, although these designs are vulnerable to time biases (policy change, seasonal change, and naturally occurring maturation). This, however, will generally be less biased than a retrospective before-and-after study, which may be easier to conduct but is the less preferred option because factors such as regression to the mean, selection bias and selective attrition can further threaten the validity of the findings. 18 Other options for comparators include a wait list control group, when matched individuals are given the intervention after a typical waiting time has passed; alternate allocation of patients between the intervention and the comparator; and between group comparison, where a similar site is identified and outcomes compared. 19 Specifying the comparator: The conundrum of 'usual care'
As telehealth is a mode of service delivery, it is as important to specify the comparator as it is the intervention. Frequently, the comparator is described only as 'usual care', however this may be either inaccurate or not the best choice to answer the research question. For example, a project compared the effectiveness of telegeriatric memory clinics in a rural town with 'usual care', but noted that general medical practitioners did not refer older adults with multiple comorbidities who were frail and unable travel to the city for assessment. Hence a comparator of 'patients that travelled for geriatric assessment' introduced a selection bias, whereas a careful review of the clinical process would have widened the scope of 'usual care' and increased the validity of the results. 19 Furthermore, 'usual care' may differ across sites, hence the telehealth alternative may be compared to varying models of care, patient groups and referral patterns, which also limits the validity of the comparison. 
Outcomes
Outcomes should be considered early and related directly to the primary purpose of the research, such as whether the research is primarily concerned with clinical metrics or service metrics. The expected size of the effect will be different depending on the measures chosen; for example a telehealth intervention might be able to produce a larger impact on length of hospital stay or numbers of physician visits, as compared with a biochemical marker such as HbA1c. This will then effect the sample size that should be planned in order for the study to be capable of showing a clinically meaningful difference. Collecting large numbers of outcome measures, or analysing outcomes from multiple subgroups as a 'fishing expedition' should also be discouraged as it is then likely that some measures produce statistically significant differences purely by chance. Table 2 lists the types of outcomes potentially applicable to telehealth research with typical examples. Consolidating this diverse range of measures into categories has been done by those constructing telehealth evaluation frameworks, 20, 21 with further work specifically on outcome measures by Brownsell and the Canadian National Telehealth Outcome Indicators project. 22, 23 The range of scales developed to specifically assess satisfaction with or experience of telehealth services will be discussed in detail in a subsequent research methods paper in this series.
With the introduction of technology it is also possible to document phenomena which were previously impractical to collect, such as every detail of patient engagement and interaction with the health system, or home monitoring records of health status. Most of these are intermediate outcomes which can be used as proxies for ultimate benefit if research shows a valid connection, such as HbA1c and diabetes outcomes, but in most cases these links have not yet been established. Finally, a major justification for introducing telehealth has been to increase access to healthcare, however measuring this concept is not straightforward. For a comprehensive discussion of access to care, including measuring the geographical, temporal, financial, cultural and digital dimensions, see the review by Fortney. 24 Statistical concepts relevant to study design
Difference, equivalence and non-inferiority
In statistical analysis of telehealth projects, the most common problem is reporting a lack of significant difference as evidence of equivalence or non-inferiority. Altman and Bland's classic statement that ''absence of evidence is not evidence of absence'' continues to be ignored. 25 Most often, statistical analysis tests the null hypothesis of no significant difference between telehealth and the comparator, then rejects the null hypothesis if the p-value is 40.05. This means that if the study was repeated many times -and imagining that the null hypothesis is truethe probability of seeing this or a greater degree of difference is less than 1 in 20. Presenting this result does not allow one to claim that both interventions are equivalent; rather, this should be done by conducting an equivalence study. These are most commonly used in drug trials but should be applied to telehealth interventions if demonstrating equivalence is the aim. The design and analysis of equivalence studies are discussed in more detail by Ebbutt and Frith and Piaggio et al.. 26, 27 Consider, however, the question that clinicians most want answered: is telehealth an inferior way of delivering care or not? A non-inferiority trial sets out to test the hypothesis that the intervention is not worse than the chosen comparator by more than a pre-determined amount. 28 For example, a single-blinded, prospective, randomized, controlled non-inferiority trial was conducted to determine if the outcomes of a 6-week telerehabilitation physiotherapy intervention for patients who had received a total knee replacement produced clinical outcomes that were not inferior to conventional face-to-face treatment. 29 Non-inferiority was determined by demonstrating that the primary outcome measure (Western Ontario and McMaster Universities Osteoarthritis Index, WOMAC) achieved in the telerehabilitation arm was not less than a predetermined inferiority margin when compared to the conventional program. The inferiority margin was set a priori at 1.3 WOMAC points based on clinical and statistical reasoning as a difference of this magnitude was unlikely to impact on the participant's functional ability.
Clinical vs statistical difference
Noting once again that telehealth is a method of service delivery, where possible the researcher should consider clinically significant differences in addition to the statistical differences, as this will be a closer indication of the difference the intervention makes in the real world. This is involves more thought than accepting the usual p 4 0.05 because the researcher also needs to look in the literature to set a figure for a clinically significant difference, which may be contested between different experts or will require a judgment call.
Confidence intervals
Whilst the p-value is the most commonly used statistic, it is good practice to report the mean difference plus the 95% confidence interval, as this allows clearer interpretation of the observed differences. The mean difference can be compared to the level of clinical significance. If one wishes to consider equivalence, the confidence interval can be pre-specified to a narrow range of, for example, À5% to þ5% and equivalence claimed if the observed interval falls within this range. In practice the best reporting approach is to present all the statistics: mean differences, confidence intervals and p-values, and also communicate the interpretation of the results in words.
Study power
Statistical power is the probability of showing a difference if it exists. Studies should therefore aim for high power (ideally over 90%) to avoid wasting the time and resources involved in running a study. Telehealth studies are often underpowered because of difficulties in recruiting patients. Researchers should look closely at existing service provision to assess the likely participant numbers and allow a generous margin, such as 50%, for refusals. Sometimes enthusiasm for the potential benefits of telehealth leads to this step being overlooked. For example, in palliative care, patients may quickly transition from not requiring home services, to needing handson care, so that there is a relatively brief period when telehealth is useful. To anticipate potential power issues, assess the likely population that could be included by gathering data on incidence, prevalence and volume of services with usual care, then check the refusal and dropout rates of participants in previous similar studies. Norman offers a useful resource for power calculations, 30 and it should be noted that power calculations will differ depending upon which statistical test is chosen. Finally, although small study sizes can cloud the evidence as the research findings are less likely to be true, 31 an underpowered but well conducted and reported study can still be valuable to a meta-analysis.
Conclusions
By attending to the above study design and analysis issues before starting a telehealth research project, potential difficulties can be avoided and greater value is added both to the scientific record and to the planning and delivery of higher quality telehealth services.
